Section: Livestock Parasites

Gastrointestinal Nematodes in Sheep: Epidemiology, Diagnosis, and Control

Introduction

Gastrointestinal nematodes (GINs) represent a major constraint to sheep production systems worldwide. These parasitic roundworms inhabit the abomasum and small intestine of sheep, causing subclinical production losses, clinical disease, and mortality in severe cases. The term "worms sheep get" colloquially refers to the complex of nematode species that infect the ovine gastrointestinal tract. The most economically significant genera include Haemonchus, Teladorsagia (formerly Ostertagia), and Trichostrongylus, with Nematodirus, Cooperia, Oesophagostomum, and Chabertia also contributing to the parasitic burden in specific epidemiological contexts. Understanding the biology, epidemiology, and control of these parasites is essential for sustainable sheep production.

Etiology and Life Cycle

The principal GINs of sheep are classified by their predilection site within the gastrointestinal tract. Abomasal parasites include Haemonchus contortus (the barber pole worm), Teladorsagia circumcincta (the brown stomach worm), and Trichostrongylus axei. Small intestinal parasites include Trichostrongylus colubriformis (the bankrupt worm), Trichostrongylus vitrinus, Nematodirus battus, Nematodirus filicollis, Cooperia curticei, and Cooperia oncophora. Large intestinal parasites include Oesophagostomum venulosum and Chabertia ovina.

All GINs share a direct life cycle. Adult female worms in the gastrointestinal lumen produce eggs that are passed in the feces. Eggs embryonate and hatch in the environment, releasing first-stage larvae (L1). Larvae develop through second (L2) and third (L3) stages. The L3 is the infective stage, enclosed in a protective cuticular sheath. Sheep ingest L3 larvae during grazing. Larvae exsheath in the rumen or abomasum and migrate to their predilection site. For most species, larvae molt to L4 and then to L5 (adults) within the host. The prepatent period varies by species: approximately 18 to 21 days for H. contortus, 14 to 21 days for T. circumcincta, and 14 to 21 days for T. colubriformis.

Epidemiology

The epidemiology of GIN infections is driven by environmental conditions, host immunity, and management practices. Temperature and moisture are the primary abiotic factors governing egg development and larval survival on pasture. Optimal conditions for egg hatching and larval development occur at temperatures between 18 and 26 degrees Celsius with adequate moisture. Desiccation, ultraviolet radiation, and extreme temperatures reduce larval survival. H. contortus is particularly sensitive to cold and is more prevalent in warm, humid regions. T. circumcincta and Trichostrongylus spp. are more adapted to temperate climates.

Seasonal patterns of infection are well characterized. In temperate regions, a periparturient rise in fecal egg counts occurs in ewes around lambing, driven by a temporary relaxation of immunity. This contaminates pastures with eggs, leading to peak larval availability in late spring and early summer. Lambs born in spring acquire infection from contaminated pasture and develop peak worm burdens in mid to late summer. N. battus exhibits a unique epidemiology, with eggs overwintering on pasture and hatching synchronously in spring after a period of chilling, leading to acute outbreaks in lambs.

Host immunity to GINs is acquired slowly and is age-related. Lambs are highly susceptible to infection. Immunity develops after repeated exposure but is often incomplete, particularly against H. contortus. Ewes develop a strong immunity but experience a periparturient relaxation. Nutritional status, particularly protein intake, influences the development and expression of immunity.

Clinical Signs and Pathogenesis

Clinical signs of GIN infection range from subclinical production losses to severe disease and death. The pathogenesis is species-specific. H. contortus is a blood-feeding parasite. Adult worms ingest blood from the abomasal mucosa, causing anemia, hypoproteinemia, and edema. Acute haemonchosis presents with sudden death, pallor of mucous membranes, and submandibular edema (bottle jaw). Subclinical infection causes reduced weight gain, decreased wool production, and impaired reproductive performance.

T. circumcincta infection causes abomasitis, with disruption of parietal cell function and reduced acid secretion. This leads to elevated abomasal pH, impaired protein digestion, and bacterial overgrowth. Clinical signs include diarrhea, weight loss, reduced appetite, and poor growth. Trichostrongylus spp. infection of the small intestine causes enteritis, villous atrophy, and malabsorption. Diarrhea, dehydration, and weight loss are common. N. battus infection in lambs causes a severe, acute enteritis with profuse watery diarrhea, dehydration, and high mortality.

Diagnosis

Accurate diagnosis of GIN infection is essential for targeted treatment and control. Diagnostic methods include clinical examination, fecal analysis, and postmortem examination.

Fecal Egg Counts

The quantitative fecal egg count (FEC) is the cornerstone of GIN diagnosis. The modified McMaster technique is the most widely used method. A known weight of feces is mixed with a flotation solution (e.g., saturated sodium chloride or sugar solution). The suspension is filtered and loaded into a McMaster counting chamber. Eggs are counted under a microscope, and the result is expressed as eggs per gram (EPG) of feces. The sensitivity of the McMaster technique is typically 50 or 100 EPG. The FEC provides an estimate of adult female worm burden but does not distinguish between species based on egg morphology alone, except for Nematodirus spp., which have larger eggs.

Larval Culture

Larval culture is used to differentiate GIN species. Feces are incubated at 22 to 27 degrees Celsius for 7 to 14 days. Larvae develop to the L3 stage and are recovered using a Baermann apparatus. Larvae are identified to genus or species based on morphological characteristics, including total length, tail length, and sheath tail morphology. Larval culture is labor-intensive but provides essential information for species-specific diagnosis and resistance testing.

Postmortem Examination

Total worm counts are the gold standard for quantifying worm burdens. The gastrointestinal tract is removed, opened, and washed. The contents are washed over a sieve, and worms are recovered, counted, and identified. This method is used for research and for confirming diagnosis in fatal cases.

Other Diagnostic Methods

FAMACHA scoring is a clinical tool for diagnosing anemia caused by H. contortus. The color of the ocular mucous membranes is compared to a standardized chart. Anemia scores correlate with H. contortus burden and guide selective treatment. Commercial ELISA kits for detecting serum antibodies or coproantigens are available for some species but are less commonly used in routine practice.

Treatment and Anthelmintic Resistance

Treatment of GIN infections relies on anthelmintic drugs. Three major classes are available: benzimidazoles (e.g., albendazole, fenbendazole), imidazothiazoles (e.g., levamisole), and macrocyclic lactones (e.g., ivermectin, moxidectin). Monepantel, a member of the amino-acetonitrile derivative class, and derquantel, a spiroindole, are newer compounds.

Anthelmintic resistance is a critical global problem. Resistance has been reported in all major GIN species to all three major drug classes. Resistance to multiple classes (multidrug resistance) is increasingly common. The mechanisms of resistance include target site mutations (e.g., beta-tubulin mutations for benzimidazole resistance), increased drug efflux (e.g., P-glycoprotein upregulation for macrocyclic lactone resistance), and altered drug metabolism.

Diagnosis of anthelmintic resistance is performed using the fecal egg count reduction test (FECRT). FEC is measured on the day of treatment and 10 to 14 days later. A reduction of less than 95% in mean FEC indicates resistance. The FECRT is the recommended field test for resistance detection.

Integrated Control Strategies

Sustainable control of GINs requires an integrated approach that reduces reliance on anthelmintics and delays the development of resistance. Key components include grazing management, selective treatment, and biological control.

Grazing Management

Pasture management aims to reduce exposure to infective larvae. Strategies include rotational grazing, mixed grazing with cattle or other species, and resting pastures. Cattle are not susceptible to most sheep GINs, so grazing cattle on contaminated pastures reduces larval contamination for sheep. Hay or silage making kills larvae on pasture.

Selective Targeted Treatment

Selective treatment reduces the number of anthelmintic treatments and maintains a refugia of susceptible worms. Refugia are worms not exposed to drug, which dilute resistant alleles in the population. FAMACHA scoring is used for selective treatment of H. contortus. Only anemic sheep are treated. For other species, treatment can be based on FEC thresholds or body condition score.

Targeted Selective Treatment

Targeted selective treatment (TST) involves treating individual animals based on indicators of parasite burden or production loss. Indicators include FEC, FAMACHA score, body weight gain, and dag score (fecal soiling). TST maintains refugia and reduces selection for resistance.

Biological Control

Nematophagous fungi, such as Duddingtonia flagrans, can reduce larval numbers on pasture. Fungal spores are fed to sheep and pass through the gastrointestinal tract. Spores germinate in feces and trap nematode larvae. This approach is not yet widely commercialized.

Vaccination

A commercial vaccine against H. contortus is available in some regions. The vaccine contains native antigens from the parasite's intestinal microvilli. Vaccination reduces worm burden and FEC but does not provide sterile immunity. Vaccination is used as part of an integrated control program.

Anthelmintic Resistance Management

To slow the development of resistance, several principles should be followed. Use anthelmintics only when necessary. Use the correct dose based on accurate body weight. Use combination products containing drugs from different classes. Avoid introducing resistant worms from purchased stock by quarantining and treating new animals. Perform regular FECRT to monitor resistance status.

Decision Tree for GIN Control

The following Mermaid diagram outlines a decision framework for managing GIN infections in a sheep flock.

flowchart TD
    A[Assess flock risk], > B{Clinical signs present?}
    B, >|Yes| C[Perform FEC and FAMACHA]
    B, >|No| D[Monitor FEC at peak risk periods]
    C, > E{High FEC or anemia?}
    E, >|Yes| F[Select anthelmintic class based on resistance history]
    E, >|No| G[No treatment, monitor]
    F, > H[Perform FECRT 10-14 days post-treatment]
    H, > I{Reduction >95%?}
    I, >|Yes| J[Effective treatment, rotate class next season]
    I, >|No| K[Resistance suspected, switch class or use combination]
    K, > L[Confirm with FECRT using alternative drug]
    D, > M{Seasonal risk period?}
    M, >|Yes| N[Consider targeted selective treatment based on FEC or FAMACHA]
    M, >|No| O[Continue monitoring]
    N, > P[Implement grazing management]
    P, > Q[Review and adjust plan annually]

Conclusion

Gastrointestinal nematodes remain a significant challenge to sheep health and productivity. Effective control requires a thorough understanding of parasite epidemiology, accurate diagnosis, and the implementation of integrated management strategies. The widespread development of anthelmintic resistance necessitates a shift from routine, calendar-based treatments to evidence-based, selective approaches. By combining grazing management, selective treatment, and resistance monitoring, producers can maintain effective parasite control while preserving the efficacy of available anthelmintics.

References

  1. Besier, R.B., Kahn, L.P., Sargison, N.D., and Van Wyk, J.A. (2016). The pathophysiology, ecology and epidemiology of Haemonchus contortus infection in small ruminants. Advances in Parasitology, 93, 95-143.
  2. Coles, G.C., Jackson, F., Pomroy, W.E., Prichard, R.K., von Samson-Himmelstjerna, G., Silvestre, A., Taylor, M.A., and Vercruysse, J. (2006). The detection of anthelmintic resistance in nematodes of veterinary importance. Veterinary Parasitology, 136(3-4), 167-185.
  3. Kaplan, R.M. (2004). Drug resistance in nematodes of veterinary importance: a status report. Trends in Parasitology, 20(10), 477-481.
  4. Knox, M.R., Besier, R.B., Le Jambre, L.F., Kaplan, R.M., and Torres-Acosta, J.F.J. (2012). Novel approaches for the control of gastrointestinal nematode parasites in livestock. Veterinary Parasitology, 186(1-2), 1-3.
  5. Leathwick, D.M. (2013). Managing anthelmintic resistance: parasite management in the future. New Zealand Veterinary Journal, 61(3), 125-133.
  6. Sargison, N.D. (2011). Pharmaceutical control of endoparasitic helminth infections in sheep. Veterinary Clinics of North America: Food Animal Practice, 27(1), 139-156.
  7. Taylor, M.A., Coop, R.L., and Wall, R.L. (2016). Veterinary Parasitology (4th ed.). Wiley Blackwell.
  8. Van Wyk, J.A., and Bath, G.F. (2002). The FAMACHA system for managing haemonchosis in sheep and goats by clinically identifying individual animals for treatment. Veterinary Research, 33(5), 509-529.
  9. Vercruysse, J., and Claerebout, E. (2001). Treatment vs non-treatment of helminth infections in cattle: defining the threshold. Veterinary Parasitology, 98(1-3), 195-214.
  10. Waller, P.J. (2006). Sustainable nematode parasite control strategies for ruminant livestock by grazing management and biological control. Animal Feed Science and Technology, 126(3-4), 277-289.

Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.